Evidence map›Paper›PMID 35088023›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2022

Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19.

David M Smadja, Olivier M Bory, Jean-Luc Diehl, Alexis Mareau, Nicolas Gendron, Anne-Sophie Jannot, Richard Chocron

Open access · goldAbstract read
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Increased Circulating CD62EStem cell reviews and reports · 2023
    Article
  8. Article
  9. D-dimer testing in clinical practice in the era of COVID-19.Research and practice in thrombosis and haemostasis · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

David M SmadjaInnovative Therapies in Hemostasis, University of Paris, Paris, France.ORCID 0000-0001-7731-9202
Olivier M BoryEmergency Department, AP-HP, Georges Pompidou European Hospital, Paris, France.
Jean-Luc DiehlInnovative Therapies in Hemostasis, University of Paris, Paris, France.
Alexis MareauMedical Informatics, Biostatistics and Public Health Department, Centre de Recherche des Cordeliers, AP-HP, University of Paris, Georges Pompidou European Hospital, European Georges Pompidou Hospital, Paris, France.
Nicolas GendronInnovative Therapies in Hemostasis, University of Paris, Paris, France.ORCID 0000-0003-4852-4738
Anne-Sophie JannotMedical Informatics, Biostatistics and Public Health Department, Centre de Recherche des Cordeliers, AP-HP, University of Paris, Georges Pompidou European Hospital, European Georges Pompidou Hospital, Paris, France.
Richard ChocronEmergency Department, University of Paris, PARCC, Georges Pompidou European Hospital, Paris, France.
Université Paris Cité · FRCentre de Recherche des Cordeliers · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Européen Georges-Pompidou · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35088023
PMCPMC8786558
OpenAlexW3216865210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.